Superior response and survival of intensive chemotherapy over venetoclax plus azacitidine in newly diagnosed KIT-mutated acute myeloid leukemia

Abstract Although KIT mutations hold significant prognostic value in acute myeloid leukemia (AML), their impact on selecting first-line treatment remains unclear. This retrospective study of 222 newly diagnosed AML patients therefore compared the efficacy of venetoclax plus azacitidine (VA) versus i...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Qingli Ji, Xinwen Jiang, Xiaoqing Li, Chen Cao, Xinrui Zhang, Minran Zhou, Sai Ma, Chunyan Chen
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Springer 2026-02-01
Serie:	Annals of Hematology
Ämnen:	Acute myeloid leukemia KIT Intensive chemotherapy Venetoclax
Länkar:	https://doi.org/10.1007/s00277-026-06841-4
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!